Skip to main content
Premium Trial:

Request an Annual Quote

EchelonDx, Oncocyte to Develop Software Supporting Commercial Diagnostics Expansion

NEW YORK – Healthcare informatics firm Echelon Diagnostics said Tuesday that it is collaborating with oncology diagnostic developer Oncocyte to develop analytical software that can scale to support the commercial expansion of Oncocyte's tests.

Based in Reno, Nevada, Echelon provides AI imaging and big data solutions supporting a range of molecular diagnostic technologies.

Irvine, California-based Oncocyte has built a pipeline of oncology diagnostic assays through acquisitions of various other companies and IP. Its first commercial offering, DetermaRx, is a 14-gene, RNA-based assay designed to identify patients with early-stage, non-small cell lung cancer who may benefit from adjuvant chemotherapy.

"EchelonDx was the right partner to help us build the software solution that allows us to scale and launch our proprietary tests worldwide in a manner that ensures … uniform and accurate testing," Oncocyte CSO Doug Ross said in a statement.

Financial terms of the agreement were not disclosed.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.